248 related articles for article (PubMed ID: 7674319)
21. p53 mutations in ovarian cancer: a late event?
Mazars R; Pujol P; Maudelonde T; Jeanteur P; Theillet C
Oncogene; 1991 Sep; 6(9):1685-90. PubMed ID: 1923532
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression.
Kim TM; Benedict WF; Xu HJ; Hu SX; Gosewehr J; Velicescu M; Yin E; Zheng J; D'Ablaing G; Dubeau L
Cancer Res; 1994 Feb; 54(3):605-9. PubMed ID: 8306317
[TBL] [Abstract][Full Text] [Related]
24. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
[TBL] [Abstract][Full Text] [Related]
25. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
[TBL] [Abstract][Full Text] [Related]
26. Aspiration cytology of neoplastic and non-neoplastic ovarian cysts: is it accurate?
Ganjei P; Dickinson B; Harrison T; Nassiri M; Lu Y
Int J Gynecol Pathol; 1996 Apr; 15(2):94-101. PubMed ID: 8786211
[TBL] [Abstract][Full Text] [Related]
27. P53, bcl-2, ki-67 li (labeling index) status in benign, proliferative, and malignant ovarian surface epithelial neoplasms.
Gursan N; Sipal S; Calik M; Gundogdu C
Eurasian J Med; 2009 Apr; 41(1):10-4. PubMed ID: 25610057
[TBL] [Abstract][Full Text] [Related]
28. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
[TBL] [Abstract][Full Text] [Related]
29. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer.
Tanos V; Prus D; Ayesh S; Weinstein D; Tykocinski ML; De-Groot N; Hochberg A; Ariel I
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):7-11. PubMed ID: 10428315
[TBL] [Abstract][Full Text] [Related]
30. Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
Yamada R; Maeda N; Oguri H; Adachi Y; Takeuchi T; Furihata M; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):96-100. PubMed ID: 24017961
[TBL] [Abstract][Full Text] [Related]
31. Fine-needle aspiration cytology of cystic ovarian lesions.
Wojcik EM; Selvaggi SM
Diagn Cytopathol; 1994; 11(1):9-14. PubMed ID: 7956669
[TBL] [Abstract][Full Text] [Related]
32. Cystadenoma and cystadenocarcinoma of the liver: a single center experience.
Vogt DP; Henderson JM; Chmielewski E
J Am Coll Surg; 2005 May; 200(5):727-33. PubMed ID: 15848365
[TBL] [Abstract][Full Text] [Related]
33. Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas.
Yu J; Roy D; Brockmeyer AD; Dubeau L
Br J Cancer; 2007 Jun; 96(12):1908-13. PubMed ID: 17519898
[TBL] [Abstract][Full Text] [Related]
34. Comparative cytogenetic and histologic studies on early malignant transformation in mesothelial tumors of the ovary.
Knoerr-Gaertner H; Schuhmann R; Kraus H; Uebele-Kallhardt B
Hum Genet; 1977 Mar; 35(3):281-97. PubMed ID: 557448
[TBL] [Abstract][Full Text] [Related]
35. In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential.
Haas CJ; Diebold J; Hirschmann A; Rohrbach H; Löhrs U
Virchows Arch; 1999 Feb; 434(2):117-20. PubMed ID: 10071245
[TBL] [Abstract][Full Text] [Related]
36. p53 expression in ovarian borderline tumors and stage I carcinomas.
Kupryjańczyk J; Bell DA; Yandell DW; Scully RE; Thor AD
Am J Clin Pathol; 1994 Nov; 102(5):671-6. PubMed ID: 7942635
[TBL] [Abstract][Full Text] [Related]
37. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
[TBL] [Abstract][Full Text] [Related]
38. ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses.
Lu D; Davila RM; Pinto KR; Lu DW
Diagn Cytopathol; 2004 May; 30(5):320-4. PubMed ID: 15108229
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms.
Zhu GG; Risteli L; Mäkinen M; Risteli J; Kauppila A; Stenbäck F
Cancer; 1995 Feb; 75(4):1010-7. PubMed ID: 7842402
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine cells in cystic mucinous tumours of the ovary.
Louwerens JK; Schaberg A; Bosman FT
Histopathology; 1983 May; 7(3):389-98. PubMed ID: 6192070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
